Flor-Essence® herbal tonic does not inhibit mammary tumor development in Sprague Dawley rats

Breast Cancer Research and Treatment

Volumn 88, Issue 1, 2004, Pages 87-93

  Michelle Bennett, L ^a   Montgomery, Jennifer L ^b   Steinberg, Seth M ^a   Kulp, Kristen S ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

complementary and alternative medicine; DMBA tumors; herbal tonic; mammary tumors; Sprague Dawley rat model

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; FLOR ESSENCE; HERBACEOUS AGENT; UNCLASSIFIED DRUG; BENZ[A]ANTHRACENE DERIVATIVE; FLOR-ESSENCE; PLANT EXTRACT;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; BREAST TUMOR; CANCER INHIBITION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; INCIDENCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; TUMOR GROWTH; ANIMAL; BEVERAGE; EXPERIMENTAL NEOPLASM; ORAL DRUG ADMINISTRATION; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; BENZ(A)ANTHRACENES; BEVERAGES; FEMALE; MAMMARY NEOPLASMS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 8744314063     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-004-1203-5     Document Type: Article

References (35)

1. Kaegi E: Unconventional therapies for cancer: 1. Essiac. CMAJ 158: 897-902, 1998
2. Richardson M, Sanders T, Tamayo C, Perez C, Palmer J: Flor-Essence® herbal tonic use in North America: a profile of general consumers and cancer patients. Herbalgram 50: 40-46, 2000
3. Ernst E: Alternative cancer cures. Br J Cancer 85: 781-782, 2001
4. Smith M, Boon H: Counseling cancer patients about herbal medicine. Patient Educ Counsel 38: 109-120, 1999
5. Canadian Breast Cancer Research Alliance. Essiac: http://www.breast. cancer.ca/ 2003
6. Stainsby M: Keeping Hope Alive. The Vancouver Sun, Vancouver, 1992
7. Complementary/Integrative Medicine. Essiac Summary: http://www. mdanderson.org/departments/cimer/ 2003
8. Mills E, Ernst E, Singh R, Ross C, Wilson K: Health food store recommendations: implications for breast cancer patients. Breast Cancer Res 5: R170-R174, 2003
9. Percival J: The Essiac Handbook, 2nd edn. Rideout Publishing Company, Orlando, FL, 1994
10. Tamayo C, Richardson M, Diamond S, Skoda I: The chemistry and biological activity of herbs used in Flor-Essence™ Herbal Tonic and Essiac™. Phytother Res 14: 1-14, 2000
11. Whitaker J: Should you take Essiac tea against cancer? Dr. Whitaker's Newsletter Vol 5, 1995
12. Burdette JE, Liu J, Lantvit D, Lim E, Booth N, Bhat KP, Hedayat S, Van Breemen RB, Constantinou AI, Pezzuto JM, Farnsworth NR, Bolton JL: Trifolium pratense (Red Clover) Exhibits Estrogenic Effects In Vivo in Ovariectomized Sprague-Dawley Rats. J Nutr 132: 27-30, 2002
13. Constantinou AI, Rossi R, Nho C-W, Jeffery EH, Xu X, van Breemen RB, Pezzuto, JM: Soy protein isolate depleted of isoflavones prevents DMBA-induced mammary tumors in female rats. Proc Am Assoc Cancer Res 41: 310, 2000
14. Fritz WA, Coward L, Wang J, Lamartiniere CA: Dietary genistein: perinatal mammary cancer prevention, bioavailability, and toxicity testing in the rat. Carcinogenesis 19: 2151-2158, 1998
15. Hilakivi-Clarke L, Cho E, Onojafe I, Raygada M, Clarke R: Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring. Oncol Rep 6: 1089-1095, 1999
16. Hirose M, Mizoguchi Y, Yaono M, Tanaka H, Yamaguchi T, Shirai T: Effects of green tea catechins on the progression or late promotion stage of mammary gland carcinogenesis in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz(a)anthracene. Cancer Lett 112: 141-147, 1997
17. Lamartiniere CA: Neonatal genistein chemoprevents mammary carcinogenesis. Proc Soc Exp Biol Med 208: 120-123, 1995
18. Zhang Z, Liu Q, Lantry LE, Wang Y, Kelloff GJ, Anderson MW, Wiseman RW, Lubet RA, You M: A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53- independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. Cancer Res 60: 901-907, 2000
19. Rogers AE, Hafer LJ, Iskander YS, Yang S: Black tea and mammary gland carcinogenesis by 7,12-dimethylbenz[a]anthracene in rats fed control or high fat diets. Carcinogenesis 19: 1269-1273, 1998
20. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170, 1966
21. Agresti A. Categorical Data Analysis. John Wiley and Sons, New York, 1990
22. Hollander M, Wolfe DA: Nonparametric Statistical Methods, 2nd edn. John Wiley and Sons, Inc., 1999, pp. 189-269
23. Hawkins RA, Hill A, Freedman B, Killen E, Buchan P, Miller WR, Forrest AP: Oestrogen receptor activity and endocrine status in DMBA-induced rat mammary tumours. Eur J Cancer 13: 223-228, 1977
24. Russo IH, Russo J: Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect 104: 938-967, 1996
25. Kronenberg F, Fugh-Berman A: Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 137: 805-813, 2002
26. Kulp KS, Montgomery JL, Latham ER, Felton JS, Bennett LM: Dietary constituents affect estrogen receptor activation and cell proliferation in MCF-7 cells. Mol Biol Cell 13: 1616, 2002
27. Bennett LM, Montgomery J, Knize MG, Latham ER, Ramsey MJ, Klotz DM, Davis BJ: The use of animal and in vitro models to study the effects of a commercially available herbal tonic on the mammary gland. Proc Am Assoc Cancer Res 43: 1037-1038, 2002
28. Tai J, Cheung S, Wong S, Lowe C: In vitro comparison of Essiac(R) and Flor-Essence(R) on human tumor cell lines. Oncol Rep 11: 471-476, 2004
29. Constantinou AI, Krygier AE, Mehta RR: Genistein induces maturation of cultured human breast cancer cells and prevents tumor growth in nude mice. Am J Clin Nut 68: 1426S-1430S, 1998
30. Bouker KB, Hilakivi-Clarke L: Genistein: does it prevent or promote breast cancer? Environ Health Perspect 108: 701-708, 2000
31. Hilakivi-Clarke L, Onojafe I, Raygada M, Cho E, Skaar T, Russo I, Clarke R: Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br J Cancer 80: 1682-1688, 1999
32. Lamartiniere CA: Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr 71: 1705S-1707S, 2000
33. Murrill WB, Brown NM, Zhang JX, Manzolillo PA, Barnes S, Lamartiniere CA: Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17: 1451-1457, 1996
34. NTP. 9th Report on Carcinogens. U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program, 2000
35. Kaijser M, Lichtenstein P, Granath F, Erlandsson G, Cnattingius S, Ekbom A: In utero exposures and breast cancer: a study of opposite-sexed twins. J Natl Cancer Inst 93: 60-62, 2001